Description
SLU‑PP‑332 is a synthetic small molecule, not a peptide. In preclinical studies it acts as a pan‑ERR (estrogen‑related receptor α/β/γ) agonist—an emerging class of exercise‑mimetic compounds. In mice and cell models, SLU‑PP‑332 increases markers of mitochondrial function, shifts muscle toward more oxidative fibers, and improves endurance and metabolic parameters. It is not FDA‑approved; real‑world products are unregulated for identity and sterility.






There are no reviews yet.